Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study

    November 2023 in “ Life
    Sibhghatulla Shaikh, Shahid Ali, Jeong Ho Lim, Khurshid Ahmad, Ki Soo Han, Eun Ju Lee, Inho Choi
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study using a virtual screening approach, eriocitrin and silymarin were identified as potent flavonoid compounds that strongly and stably interacted with 5α-reductase type II, suggesting potential development as novel treatments for androgenic alopecia.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the potential of natural compounds as inhibitors of 5α-reductase type II (5αR2), an enzyme linked to androgenic alopecia (AGA), a common form of hair loss. The researchers screened 241 flavonoid compounds and identified two potent compounds, eriocitrin and silymarin, that interacted strongly with 5αR2. These compounds had binding energies of -12.1 and -11.7 kcal/mol, respectively, which were more significant than the control, finasteride (-11.2 kcal/mol). Molecular dynamic simulations confirmed the stability of these interactions. The study concludes that eriocitrin and silymarin could provide a basis for the development of novel 5αR2 inhibitors for the management of AGA. However, further experimental research is needed to optimize these compounds as 5αR2 inhibitors.
    Discuss this study in the Community →

    Research cited in this study

    18 / 18 results